Hologic Inc (MEX:HOLX)
MXN 1207.71 0 (0%) Market Cap: 353.23 Bil Enterprise Value: 359.80 Bil PE Ratio: 22.68 PB Ratio: 3.41 GF Score: 86/100

Hologic Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 01:30PM GMT
Release Date Price: MXN1265.13
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Hey, everyone. Good morning. Thank you for joining us. My name is Tejas Savant, I cover Life Science Tools and Diagnostics here at Morgan Stanley.

Before we begin, I'd like to remind investors that important disclosure information can be found at morganstanley.com/researchdisclosures. Before -- Yes, so it's my pleasure today to have the Chairman, CEO and President of Hologic, Steve MacMillan here on stage with me. Thank you for joining us, Steve.

Stephen P. MacMillan
Hologic, Inc. - Chairman, CEO & President

Thanks for having us, Tejas.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

Lots to chat about so let's get right to it. I'll start with the core diagnostics franchise, right? So as you think about the COVID sales unwinding, you've seen strong growth in the non-COVID piece of the portfolio. I think the guide embed something like low double-digit growth this year. How

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot